Ashwath Jayagopal - OCUP Old Chief Officer
Executive
Ashwath Jayagopal is Chief Officer of OCUP Old
| Age | 42 |
| Phone | (248) 957-9024 |
| Web | https://www.ocuphire.com |
Ashwath Jayagopal Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ashwath Jayagopal against OCUP Old stock is an integral part of due diligence when investing in OCUP Old. Ashwath Jayagopal insider activity provides valuable insight into whether OCUP Old is net buyers or sellers over its current business cycle. Note, OCUP Old insiders must abide by specific rules, including filing SEC forms every time they buy or sell OCUP Old'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ashwath Jayagopal over three weeks ago Disposition of 5193 shares by Ashwath Jayagopal of Opus Genetics, at 1.15 subject to Rule 16b-3 | ||
Ashwath Jayagopal over three months ago Acquisition by Ashwath Jayagopal of 75000 shares of Ocuphire Pharma subject to Rule 16b-3 |
OCUP Old Management Efficiency
The company has return on total asset (ROA) of (0.2135) % which means that it has lost $0.2135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3601) %, meaning that it created substantial loss on money invested by shareholders. OCUP Old's management efficiency ratios could be used to measure how well OCUP Old manages its routine affairs as well as how well it operates its assets and liabilities.OCUP Old currently holds 4.04 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. OCUP Old has a current ratio of 5.3, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about OCUP Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Bruce MD | Mustang Bio | N/A | |
| Debra SPHR | Mustang Bio | N/A | |
| John Doyle | Cognition Therapeutics | 48 | |
| Tony Cardinale | Eyenovia | N/A | |
| Norbert Lowe | Eyenovia | N/A | |
| David Jones | Eyepoint Pharmaceuticals | 56 | |
| Michael Louie | Kodiak Sciences | N/A | |
| Enrico Brambilla | Eyenovia | N/A | |
| Robyn Hunter | Fortress Biotech Pref | 61 | |
| Daniel MD | Transcode Therapeutics | 73 | |
| Dario Paggiarino | Eyepoint Pharmaceuticals | 67 | |
| Yael Fellous | Protalix Biotherapeutics | N/A | |
| Ramiro MD | Eyepoint Pharmaceuticals | 42 | |
| Tarek Sallam | Rigel Pharmaceuticals | N/A | |
| Said Saim | Eyepoint Pharmaceuticals | 66 | |
| Michael Maciocio | Eyepoint Pharmaceuticals | N/A | |
| Robyn Hunter | Fortress Biotech | 62 | |
| Richard MS | Mustang Bio | N/A | |
| Robyn Hunter | Mustang Bio | 63 | |
| Andrew Elnatan | Sellas Life Sciences | N/A | |
| Alan Freidman | Transcode Therapeutics | N/A | |
Management Performance
| Return On Equity | -0.36 | |||
| Return On Asset | -0.21 |
OCUP Old Leadership Team
Elected by the shareholders, the OCUP Old's board of directors comprises two types of representatives: OCUP Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OCUP. The board's role is to monitor OCUP Old's management team and ensure that shareholders' interests are well served. OCUP Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OCUP Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, VP Officer | ||
| Richard MBA, Interim Director | ||
| Bernhard MBA, Senior Secretary | ||
| MAcc CPA, Senior Finance | ||
| Erik Sims, Director Controller | ||
| MBA MD, CEO Director | ||
| Joseph MBA, Chief Officer | ||
| Ronil MS, Chief Officer | ||
| Daniela Oniciu, Chemistry RD | ||
| Mitchell Brigell, Head Strategy | ||
| Chris Ernst, Global Manufacturing | ||
| Bindu Manne, Head Commercialization | ||
| Ashwath Jayagopal, Chief Officer | ||
| Nirav CFA, Chief Officer | ||
| MBA MBA, CEO, Founder |
OCUP Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OCUP Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.36 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (0.86) % | |||
| Operating Margin | (7.49) % | |||
| Current Valuation | (6.57 M) | |||
| Shares Outstanding | 26.2 M | |||
| Shares Owned By Insiders | 7.33 % | |||
| Shares Owned By Institutions | 10.44 % | |||
| Number Of Shares Shorted | 930.64 K | |||
| Price To Book | 0.86 X |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in OCUP Stock
If you are still planning to invest in OCUP Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OCUP Old's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance |